Fmoc-D-Thr(Bzl)-OH

Fmoc-D-Thr(Bzl)-OH is an Fmoc-protected D-threonine derivative bearing a benzyl-protected side-chain hydroxyl, giving a chiral amino acid building block with orthogonally protected functional groups. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) carbamate that supports base-stable handling during peptide assembly, while the C-terminal carboxylic acid remains available for amide bond formation. The D stereocenter at the alpha position and the benzyl ether on the side-chain hydroxyl provide stereochemical definition and controlled reactivity, enabling selective deprotection and subsequent functionalization. The benzyloxy group can be removed under hydrogenolysis conditions, and the free carboxylate and carbamate-protected amine are compatible with standard peptide coupling chemistries used in synthetic organic and peptide chemistry workflows.

1. Peptide Synthesis

Fmoc-D-Thr(Bzl)-OH is used as a protected amino acid building block for solid-phase and solution-phase peptide synthesis where orthogonal protection is required. The Fmoc carbamate enables iterative N-terminal deprotection and coupling cycles, while the D-configuration at the alpha carbon supports incorporation of stereodefined residues into peptide chains. The benzyl-protected threonine side-chain hydroxyl prevents undesired side reactions during coupling and allows controlled downstream unveiling for phosphorylation, glycosylation, or conjugation chemistry. The resulting D-threonine-containing peptide products can serve as substrates, standards, or analog scaffolds in peptide science and synthetic methodology development.

2. Side-Chain Functionalization

Fmoc-D-Thr(Bzl)-OH is applied in amino acid modification workflows that target threonine side-chain derivatization after peptide assembly or as a chiral intermediate in fragment synthesis. The benzyl ether protects the hydroxyl group during peptide coupling, then can be removed to generate a free secondary alcohol for further transformations such as ester formation, etherification, or tether installation for molecular recognition studies. The presence of the Fmoc group supports selective deprotection without requiring immediate side-chain exposure, enabling stepwise control over functional group availability. Downstream derivatives produced from the deprotected threonine hydroxyl can be used to generate peptidomimetics, linker-bearing analogs, and chemically defined substrates for biochemical assays.

3. Chiral Building Block Development

Fmoc-D-Thr(Bzl)-OH is suitable for chiral synthesis programs that require D-amino acid incorporation to modulate conformational preferences and proteolytic stability in peptide-like molecules. The defined D stereocenter and the orthogonally protected side-chain hydroxyl provide a controlled stereochemical handle for constructing enantiomerically specified sequences or stereochemically rich intermediates. The Fmoc-protected amine and carboxylic acid functionality allow straightforward conversion into amide-linked structures while maintaining the protected alcohol for later functional group unveiling. The compound can therefore be employed as a stereochemically defined intermediate for producing D-configured peptide analogs used in structure-activity relationship studies and chiral molecular design.

4. Chemical Biology Research

Fmoc-D-Thr(Bzl)-OH supports chemical biology and biochemical research where threonine-containing motifs are required with controlled functional-group exposure. The protected hydroxyl and Fmoc carbamate allow assembly of peptides that remain chemically stable during handling, purification, and conjugation steps until side-chain deprotection is intentionally triggered. The D-threonine residue can be incorporated into peptide probes to tune binding behavior and resistance to enzymatic degradation, facilitating studies of molecular recognition, substrate specificity, and interaction mapping. The resulting D-threonine-bearing peptides and conjugates can be used as defined reagents for mechanistic investigations and analytical reference materials in biochemical workflows.

5. Pharmaceutical Manufacturing

Fmoc-D-Thr(Bzl)-OH can be incorporated into manufacturing-oriented peptide intermediate production where orthogonal protection strategies reduce process complexity and improve reproducibility. The Fmoc group provides a robust N-protection scheme compatible with iterative coupling and controlled deprotection operations, while the benzyl-protected side-chain hydroxyl minimizes side reactions during synthesis of threonine-containing sequences. The carboxylic acid functionality enables formation of amide linkages under standardized peptide coupling conditions, supporting scalable intermediate preparation for peptide-based active ingredients and related process streams. Downstream, the protected residue can be converted into final threonine-containing intermediates after staged deprotection, aligning with industrial peptide synthesis practices and fine chemical production requirements.

6. Fine Chemical Synthesis

Fmoc-D-Thr(Bzl)-OH is applicable in fine chemical synthesis as a chiral amino acid derivative for constructing stereodefined amide frameworks and protected alcohol-containing intermediates. The orthogonal protection pattern allows sequential functional group management, with the Fmoc carbamate governing N-reactivity and the benzyl ether preserving the threonine hydroxyl for later derivatization. The compound's carboxylic acid and protected amine enable its use in building chiral fragments that can be coupled into larger molecules, including peptidomimetic scaffolds and linker-bearing constructs. The resulting intermediates support downstream synthesis of functionalized amino acid derivatives and chemically defined materials used in applied research and specialty chemical production.

1. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle